lemaitre.com (LMAT): Operatsion rentabellik

LeMaitre Corp (LMAT) - korporativ logo

LeMaitre Vascular, Inc. (LMAT) o'zining hayotiy muhim implantlarining ishonchliligiga asoslangan holda tomir jarrohligi sohasida benuqson obro'ga ega. Operatsion marja tendentsiyasi xarajatlar samaradorligining bozor tomonidan baholanishini aks ettiradi, bunda 27.70 qiymati ushbu ko'rsatkichning joriy holatini ifodalaydi. Yuqori daromadlilik patentlar va global sotuvlar hisobiga ta'minlanmoqda. Barqaror rahbarlik va qarzlardan xoli balans hisoboti kapitalni boshqarishning a’lo darajadagi intizomini kafolatlaydi.

LMAT - LeMaitre Vascular Operatsion foyda koeffitsiyenti 04.07.2022 - 20.11.2026 oraligʻida

LeMaitre Vascular, Inc. (LMAT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental tahlili:LMAT, LeMaitre Corp
LeMaitre Corp asosiy tovari

LeMaitre Vascular, Inc. (LMAT) qon tomir jarrohligi asboblarining diversifikatsiyalashgan portfelini saqlaydi, bu esa umumiy daromadga nisbatan asosiy faoliyatdan olingan foyda ulushini aks ettirgan holda operatsion marjan barqarorligini ta'minlaydi. Asosiy faoliyatdan olingan marjinal daromad tahlili qarz xizmatlari va soliqlarni istisno qilgan holda xarajatlarni boshqarish samaradorligini baholash imkonini beradi va kompaniyaning biznes modelining bozor tebranishlariga yuqori chidamliligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

ISRG (intuitive.com) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi DHR (Danaher Corp.)|Sotuvning operatsion marjasi BDX (Becton, Dickinson and Company)|Operatsion foyda koeffitsiyenti STE|Operatsion rentabellik West Pharma WST|Operatsion faoliyat rentabelligi Baxter (BAX)|MASI - Operatsion rentabellik|Operatsion faoliyat rentabelligi Stevanato Group Corp STVN|TFX: Operatsion marja|Sotuvning operatsion marjasi Merit Medical Systems|Operatsion rentabellik Envista Holdings Corp|Sotuvning operatsion marjasi ICU Medical Corp (ICUI)|Operatsion rentabellik DENTSPLY SIRONA Inc. (XRAY)|ATRC (AtriCure Corp) - Operatsion foyda normasi|Operatsion marja STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Sotuvning operatsion rentabelligi|ZimVie Inc - Operatsion marja|Sotuvning operatsion rentabelligi AngioDynamics|CERS (Cerus Corp) - Sotuvning operatsion marjasi|Alpha Teknova, Inc. - Operatsion foyda normasi|MGRM (Monogram Orthopedics Inc.) - Operatsion marja|STSS: Operatsion foyda normasi|Sotuvning operatsion marjasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja KRMD (korumedical.com)|Operatsion faoliyat rentabelligi Nyxoah, S.A. (NYXH)|MBOT - Operatsion rentabellik|PDEX (Pro-Dex, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|ZTEK (Zentek Ltd) - Sotuvning operatsion marjasi|ELUT - Operatsion faoliyat rentabelligi|MLSS (Milestone Scientific Corporation) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi NXGL (NEXGEL, Inc.)|Operatsion marja RVP|Sotuvning operatsion marjasi Harvard Bioscience HBIO|Operatsion marja FEMY (Femasys Corporation)|MHUA - Sotuvning operatsion marjasi|POAI - Operatsion rentabellik|Callan JMB (CJMB) - Sotuvning operatsion marjasi|ATRI: Operatsion marja|NURO - Operatsion faoliyat rentabelligi